Clinical Built Support Articles & Analysis
22 articles found
In November 2024, the British Thoracic Society (BTS), Scottish Intercollegiate Guidelines Network (SIGN), and the National Institute of Care Excellence (NICE) asthma guidelines1 were released superseding the previously separate guidelines from BTS/SIGN2 and NICE3. The new joint guideline, based on current clinical evidence and cost-effective modelling, clears up the previous uncertainty about the ...
Stoptober takes place every October in the UK. Launched in 2012, the campaign encourages smokers to quit for 28 days. The theme for 2024 is ‘When you stop smoking, good things start to happen’. Bedfont® Scientific Ltd., world leaders in breath analysis, hosted a discussion with Smokerlyzer® Medical Advisory Board Members Dr Amer Siddiq Amer Nordin and Dr Anne Yee. The panel ...
Antibodies are an essential part of our immune system, capable of recognizing foreign molecules (antigens) and helping to eliminate them. Antibodies have a high degree of target specificity, affinity, and safety, and have been widely used in the treatment, diagnosis, and prevention of many major diseases. They are currently a focus in new drug development. The design of antibody drugs is a ...
In today’s healthcare environment, the general consensus is that the exchange and flow of data is crucial and beneficial to developing better care of the patients. Healthcare information exchanges (HIEs), as an example, have shown to be effective in improving public health, reducing healthcare redundancies, and providing clinical providers with more support tools in their day-to-day work. ...
While open relationships can be problematic, combining the open standards FHIR and BPM+ Health with Medical Algorithms is a match made in heaven. This combination has the potential to revolutionize healthcare. To see why this statement is true, let’s first introduce the participants. ...
Do you want to learn how to build quality clinical studies faster and easier? Then let’s connect! Chat with our friendly team Just drop by booth #8 at any time during the conference to talk to us about: starting studies from scratch seeing how eCRFs look and work before your EDC database is built avoiding the pain of lengthy review/approval cycles ...
ByFormedix
Executive Brief On September 28, 2022, the FDA released Clinical Decision Support, Guidance for Industry and Food and Drug Administration Staff. This guidance is long overdue, and with it comes the elimination of any protections for EHRs, or any other vendors, to pretend it’s OK to sell or deploy solutions for patient monitoring and care for life-threatening conditions like sepsis, that ...
The term sepsis describes the body's extreme response to infection. When a person suffers from sepsis, his or her immune system has been triggered in response to an infection, which causes inflammation and damages tissues in the body. Symptoms of Sepsis The symptoms of sepsis may include: Fever (102 degrees Fahrenheit or higher) Chills Rapid breathing (above 20 breaths per minute) or ...
We are excited to announce a beta release of our Calypso tool on the latest Phase II Undiagnosed Diseases Network (UDN) data. This is a project performed in collaboration with the UDN, and we encourage our initial set of UDN investigators to trial this release and provide any feedback, comments, questions or requests to info@frameshit.io. ...
For patients and parents recently affected by or managing short bowel syndrome, TPN is likely new to their vocabulary. While any clinical acronym may sound overwhelming, TPN is not such a complicated one to understand. ...
Revisiting the “why” behind decision making can be a helpful exercise in all aspects of business. This is no less true for clinical operations executives when it comes to the clinical trial systems they employ to facilitate their teams’ work. The technology that supports clinical trial systems has evolved steadily over the past several decades, yet the ultimate goal of ...
Researchers at The University of Texas MD Anderson Cancer Center have identified a new strategy to reduce immune-related adverse events by targeting immunotherapy with the cytokine interleukin-6 (IL-6). The study, published in Cancer Cell, provides evidence for the concept of combining immune checkpoint blockers and cytokine blockers to selectively inhibit inflammatory autoimmune responses. ...
And yet the 30 to 50 question decision tree symptom checker is built on the assumption that the patient most likely can’t do this. ...
Treatment of pediatric soft tissue wounds presents additional complexities and highlights unique requirements. This piece provides a synopsis of an article [1] published in the Journal of Pediatric Surgery Case Reports by Dr. Kyle Crowley and his colleagues from the Division of Paediatric Surgery at Townsville University Hospital in Queensland, Australia. NovoSorb® BTM, a biodegradable ...
Our Value-Based Robotics series advances towards the actual clinical use of robotics and issues concerning practicality and surgeon onboarding and training. It is generally accepted that robotic surgical systems enable minimally invasive surgery and improve outcomes, including shorter recovery times, less scarring, and reduced healthcare costs. This being said, the jury is still out on whether ...
Whether your clinical operations team sits in a large sponsor company, or in one that’s still growing, it must be supported by efficient systems to maintain high productivity. Clinical trial protocols must be conducted with quality, within budget, and within timelines. To achieve this, Clinical Program Managers and their teams must be able to rely on 4 things: A strong ...
A head-to-head comparison shows that the Retia Argos Monitor accurately tracks changes in CO as the vena cava is clamped and unclamped during liver surgery, while the leading competitor monitor fails. As shown, the Argos Monitor tracks with the reference standard, while the competitor monitor shows increasing CO when the vena cava is clamped and CO is actually decreasing (205 – 210 ...
With Regeneron’s high profile, single-person, single-site, clinical trial proving successful (along with much supporting other clinical data!), will neutralising antibodies surf the second wave? Our COVID-related blogs focus on capacity and cost of making the treatments and understanding opportunities or bottlenecks in large scale provision and new innovations. In this context, we review ...
The Problem: When Kevin Kronmiller was 22, he found out he had 5 years to live if he didn't receive a liver transplant. Beating the odds, Kevin made it to 50 before needing a liver transplant. After his surgery, Kevin went into Septic Shock. He found out later from his physicians that he had a 30% chance of survival and even if he did survive, doctors were very concerned about long-term ...
Inspired by the superb vision and natural mechanism of the eagle's eye, Algatechnologies introduces AstaPure® EyeQ. a clinically supported, microencapsulated, cold water-soluble 2% natural astaxanthin powder. AstaPure® EyeQ is a highly pure extract derived from Haematococcus pluvialis microalgaer a species of microalgae known to be the richest source of natural astaxanthin. As a ...
ByAlgatech